申请人:G. D. Searle & Co.
公开号:US04760180A1
公开(公告)日:1988-07-26
This invention encompasses compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof wherein R.sup.1 is lower alkoxy or --O--(CH.sub.2).sub.n -phenyl where the phenyl may be optionally substituted with halogen, --NO.sub.2, --CN, --NH.sub.2 or lower alkyl wherein n is 1 to 4; R.sup.2 and R.sup.3 represent lower alkyl, halogen, lower alkoxy or one of R.sup.2 or R.sup.3 is hydrogen and the other is lower alkyl, lower alkoxy, or halogen; R.sup.4, R.sup.5, R.sup.7, R.sup.8, and R.sup.9 represent hydrogen or lower alkyl, R.sup.6 represents hydrogen, lower alkyl, lower alkenyl, or --(CH.sub.2).sub.m -cycloalkyl wherein m is 1 to 4 and the cycloalkyl has 3 to 8 carbon atoms; R.sup.10 is --(CH.sub.2).sub.p -phenyl wherein p is 1 to 4; and v represents an asymmetric carbon that may be racemic or have the D or L Configuration; w represents an asymmetric carbon when R.sup.7 and R.sup.8 are not the same that may be racemic or have the D or L configuration. This invention also encompasses compounds where R.sup.1 is hydroxy, provided at least one of R.sup.4, R.sup.5, R.sup.6 or R.sup.9 is lower alkyl. The compounds of this invention are useful analgesic agents.
这项发明涵盖了以下公式的化合物及其药学上可接受的酸加盐,其中R.sup.1是较低的烷氧基或--O--(CH.sub.2).sub.n -苯基,其中苯基可能选择性地被卤素、--NO.sub.2、--CN、--NH.sub.2或较低烷基取代,其中n为1到4;R.sup.2和R.sup.3代表较低的烷基、卤素、较低的烷氧基或R.sup.2或R.sup.3中的一个是氢,另一个是较低的烷基、较低的烷氧基或卤素;R.sup.4、R.sup.5、R.sup.7、R.sup.8和R.sup.9代表氢或较低的烷基,R.sup.6代表氢、较低的烷基、较低的烯烃基或--(CH.sub.2).sub.m -环烷基,其中m为1到4,环烷基有3到8个碳原子;R.sup.10是--(CH.sub.2).sub.p -苯基,其中p为1到4;v代表一个可能是外消旋的或具有D或L构型的不对称碳;w代表一个可能是外消旋的或具有D或L构型的不对称碳,当R.sup.7和R.sup.8不相同时。这项发明还涵盖了R.sup.1为羟基的化合物,只要R.sup.4、R.sup.5、R.sup.6或R.sup.9中至少有一个是较低的烷基。这项发明的化合物是有用的镇痛剂。